| mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0057 |
0.9 |
| mRNA |
SN-38 |
GDSC1000 |
pan-cancer |
AAC |
-0.0053 |
0.9 |
| mRNA |
RAF265 |
FIMM |
pan-cancer |
AAC |
0.024 |
0.9 |
| mRNA |
VX-702 |
GDSC1000 |
pan-cancer |
AAC |
-0.0056 |
0.9 |
| mRNA |
AZD6244 |
UHNBreast |
pan-cancer |
AAC |
0.04 |
0.9 |
| mRNA |
BRD-K29086754 |
CTRPv2 |
pan-cancer |
AAC |
0.012 |
0.9 |
| mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
0.0057 |
0.9 |
| mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0057 |
0.9 |
| mRNA |
CID-5951923 |
CTRPv2 |
pan-cancer |
AAC |
-0.006 |
0.9 |
| mRNA |
SB590885 |
GDSC1000 |
pan-cancer |
AAC |
0.0049 |
0.9 |